Summary | Human Antibody for Deploying CH2-Based Therapeutics

Crowdsourcing scientists around the world with orphan and dormant intellectual property (IP).

Join Us Sign In

This is the pilot version of Therapoid. Register or Sign in as a pilot user to collaborate.

Provided by: National Institutes of Health (NIH)
Tags: CH2 effector functions nanoantibodies conformational epitope IgG

Short Description:

This technology pertains to a human antibody that could be used safely in vitro and in vivo for the detection of CH2, Fc, and IgG.